These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 6173842)

  • 1. [Efficacy of aprotinin in insulin resistance caused by subcutaneous degradation of insulin].
    Sudre Y; Marechaud R; Abadie JC; Rossi F; Gouet D
    Nouv Presse Med; 1982 Jan; 11(2):131-2. PubMed ID: 6173842
    [No Abstract]   [Full Text] [Related]  

  • 2. Diabetes resistant to subcutaneous insulin: effect of aprotinin.
    N Engl J Med; 1981 Dec; 305(23):1413-4. PubMed ID: 6170889
    [No Abstract]   [Full Text] [Related]  

  • 3. Resistance against subcutaneous insulin successfully managed with aprotinin.
    Müller WA; Taillens C; Léreret S; Berger M; Philippe J; Halban PA; Offord RE
    Lancet; 1980 Jun; 1(8180):1245-6. PubMed ID: 6155578
    [No Abstract]   [Full Text] [Related]  

  • 4. Subcutaneous-insulin-resistance syndrome.
    N Engl J Med; 1987 Jan; 316(1):49-51. PubMed ID: 3537795
    [No Abstract]   [Full Text] [Related]  

  • 5. [On the therapy of insulin resistance].
    Müller L
    Med Klin; 1967 Dec; 62(49):1916-8. PubMed ID: 5589259
    [No Abstract]   [Full Text] [Related]  

  • 6. Dramatic improvement of subcutaneous insulin resistance with nafamostat ointment treatment.
    Kawashima S; Kaneto H; Sakamoto K; Honsho I; Yasuda T; Kuroda A; Shiraiwa T; Kasami R; Matsuoka TA; Yamasaki Y; Matsuhisa M
    Diabetes Care; 2008 Mar; 31(3):e11. PubMed ID: 18308674
    [No Abstract]   [Full Text] [Related]  

  • 7. [Insulin resistance. Frequently administration errors are the source].
    Rendschmidt T; Lüddeke HJ; Renner R; Hepp KD
    MMW Fortschr Med; 2000 May; 142(21):38-41. PubMed ID: 10872293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of aprotinin on the absorption of subcutaneously injected regular insulin in normal subjects.
    Berger M; Cüppers HJ; Halban PA; Offord RE
    Diabetes; 1980 Jan; 29(1):81-3. PubMed ID: 6155298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin allergy and insulin resistance.
    Goldfine AB; Kahn CR
    Curr Ther Endocrinol Metab; 1994; 5():461-4. PubMed ID: 7704774
    [No Abstract]   [Full Text] [Related]  

  • 10. A lecithin-based microemulsion of rh-insulin with aprotinin for oral administration: Investigation of hypoglycemic effects in non-diabetic and STZ-induced diabetic rats.
    Cilek A; Celebi N; Tirnaksiz F; Tay A
    Int J Pharm; 2005 Jul; 298(1):176-85. PubMed ID: 15950411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Insulin resistance caused by an increase in proteolytic enzyme activity at the site of insulin injection. Study in insulin-dependent diabetic subjects].
    Calle Pascual AL; Marañes Pallardó JP; Charro Salgado AL
    Med Clin (Barc); 1983 Apr; 80(12):524-6. PubMed ID: 6191160
    [No Abstract]   [Full Text] [Related]  

  • 12. Subcutaneous aprotinin causes local hyperaemia. A possible mechanism by which aprotinin improves control in some diabetic patients.
    Williams G; Pickup JC; Bowcock S; Cooke E; Keen H
    Diabetologia; 1983 Feb; 24(2):91-4. PubMed ID: 6188643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Coincidence of hepatic angiosarcoma and insulin-resistance diabetes mellitus with high-dose intraperitoneal insulin therapy].
    Kersten A; Schwarzkopf J; Petersen KG; Lohner M
    Verh Dtsch Ges Pathol; 1994; 78():285-7. PubMed ID: 7534000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subcutaneous degradation of insulin.
    Stevenson RW
    Diabetologia; 1982 Mar; 22(3):221-3. PubMed ID: 6176491
    [No Abstract]   [Full Text] [Related]  

  • 15. Insulin kinetics.
    Kapur A
    J Assoc Physicians India; 1997; Suppl 1():13-7. PubMed ID: 11235628
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of type I diabetic with subcutaneous insulin resistance by a totally implantable insulin infusion device ("Infusaid").
    Campbell IW; Kritz H; Najemnik C; Hagmueller G; Irsigler K
    Diabetes Res; 1984 Jul; 1(2):83-8. PubMed ID: 6442226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conventional and human insulin: complications of insulin therapy in children.
    MacDonald MJ
    Prim Care; 1983 Dec; 10(4):691-706. PubMed ID: 6371864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical efficacy of subcutaneous insulin: the role in pregnancy.
    Roy Chowdhury S; Kumar B; Stanaway SE
    Int J Clin Pract; 2007 Feb; 61(2):349-50. PubMed ID: 17263725
    [No Abstract]   [Full Text] [Related]  

  • 19. Lipoatrophic diabetes mellitus treated by continuous subcutaneous insulin infusion.
    Meyer L; Hadjadj S; Guerci B; Delbachian I; Ziegler O; Drouin P
    Diabetes Metab; 1998 Dec; 24(6):544-6. PubMed ID: 9932222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin analog lispro decreases insulin resistance and improves glycemic control in an obese patient with insulin-requiring type 2 diabetes.
    Darmon P; Curtillet C; Boullu S; Laugier A; Dutour A; Oliver C
    Diabetes Care; 1998 Sep; 21(9):1575. PubMed ID: 9727917
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.